Management of osteoporosis: Is there a role for vitamin K?

International Journal for Vitamin and Nutrition Research

Volumn 67, Issue 5, 1997, Pages 350-356

  Weber, Peter ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

Calcium; Epidemiology; Intervention; Osteocalcin; Osteoporosis; Requirements; Vitamin K

Indexed keywords

VITAMIN K GROUP;

ARTICLE; BONE DENSITY; DRUG EFFECT; FEMALE; HUMAN; MALE; OSTEOPOROSIS; PATHOPHYSIOLOGY;

BONE DENSITY; FEMALE; HUMANS; MALE; OSTEOPOROSIS; VITAMIN K;

EID: 0030776479     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Chapuy, M. C. and Meunier, P. J. (1995) Prevention and treatment of osteoporosis. Aging Clin. Exp. Res. 7, 164-173.
2. NIH Consensus Statement. (1995) Optimal calcium intake. Nutrition 11, 409-417.
3. Riggs, B. L. and Melton, L. J. Jr. (1995) The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17, 505S-511S.
4. Cooper, C., Campion, G. and Melton, L. J. III (1992) Hip fractures in the elderly: a worldwide projection. Osteoporosis Int. 2, 285-289.
5. Fraser, D. R. (1995) Vitamin D. Lancet 345, 104-107.
6. Heaney, R.P. (1993) Bone mass, nutrition, and other life-style factors. Am. J. Med. 95, 5A-29S.
7. Lindsay, R. (1993) Prevention and treatment of osteoporosis. Lancet 341, 801-805.
8. Sojka, J. E. and Weaver, C. M. (1995) Magnesium supplementation and osteoporosis: Nutr. Rev. 53, 71-74.
9. Anderson, J. J.B., Rondano, P. and Holmes, A. (1996) Nutrition, life style and quality of life. Scand. J. Rheumatol. 25, 65-74.
10. Binkley, N. C. and Suttie, J. W. (1995) Vitamin K nutrition and osteoporosis. J. Nutr. 125, 1812-1821.
11. Suttie, J. W. (1991) Vitamin K. In: Handbook of Vitamins (Machlin, L. J., ed.), Second Edition, Revised and Expanded, pp. 145-194, Marcel Dekker, Inc., New York.
12. Vermeer, C., Knapen, M. H. J., Jie, K. S. G. and Grobbee, D. E. (1992) Physiological importance of extra-hepatic vitamin K-dependent carboxylation reactions. Ann. N. Y. Acad. Sci. 669, 21-33.
13. Suttie, J. W. (1995) Vitamin K-dependent carboxylase. Ann. Rev. Biochem. 54, 459-477.
14. Robey, P. G. and Borkey, A. L. (1996) GLA-containing proteins. In: Osteoporosis (Marcus, R., Feldmann. D. and Lelsey, J., eds.), pp. 142-146, Academic Press, New York.
15. Price, P. A. (1989) GLA-containing proteins of bone. Connective Tissue Res. 21, 51-60.
16. Delmas, P. D., Malaval, L., Arlot, M. E. and Meunier, P. J. (1985) Serum bone Gla-protein compared to bone histomorphometry in endocrine diseases. Bone 6, 339-341.
17. Bach, A. U., Anderson, S. A., Foley, A. L., Williams, E. C. and Suttie, J. W. (1995) Sensitivity of various indices of human vitamin K deficiency. FASEB J. 9, A726 (abstract).
18. Shearer, M. J. (1995) Vitamin K. Lancet 345, 229-234.
19. Ferland, G., Sadowski, J. A. and O'Brien, M. E. (1993) Dietary induced subclinical vitamin K deficiency in normal human subjects. J. Clin. Invest. 91, 1761-1768.
20. b in growing and ovariectomized rats. Osteop. Lit. 6, S141.
21. Koshihara, Y., Hoshi, K. and Shiraki, M. (1993) Vitamin K2 (menatetrenon) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity. Biochem. Pharmacol. 46, 1355-1362.
22. Reddi, K., Henderson, B., Meghji, S., Wilson, M., Poole, S., Hopper, C., Harris, M. and Hodges, S. J. (1995) Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine 7, 287-290.
23. 1 in osteoporosis. J. Clin. Endocrinol. Metab. 60, 1268-1269.
24. Hodges, S. J., Pilkington, M. J., Stamp, T. C. B., Catterall, A., Shearer, M. J., Bitensky, L. and Chayen, J. (1991) Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 12, 387-389.
25. 2 decreased in elderly women with hip fracture. J. Bone Mineral Res. 8, 1241-1245.
26. Tamatani, M., Morimoto, S., Nakajima, M., Fukus, O. (1995) Participation of decreased circulation levels of vitamin K in bone mineral loss of elderly men. J. Bone Mineral Res. 10, S248.
27. Jie, K. S. G., Bots, M. L., Vermeer, C., Witteman, J. C. M. and Grobbee, D. E. (1996) Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif. Tissue Int. 59, 352-356.
28. Szulc, P., Chapuy, M. C., Meunier, P. J. and Delmas, P. D. (1993) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J. Clin. Invest. 91, 1769-1774.
29. Szulc, P., Arlot, M., Chapuy, M. C., Dubofuf. F., Meunier, P. J. and Delmas, P. D. (1994) Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J. Bone Min. Res. 9, 1591-1595.
30. Szulc, P., Chapuy, M. C., Meunier, P. J. and Delmas, P. D. (1996) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 18, 487-488.
31. Houvenagel, E., Leloire, O., Vanderlinden, T., Graux, P., Dutoit, A., Tison, F., Forzy, G., Bacadot, A. and Vincent, G. (1989) Taux d'osteocalcine et masse osseuse chez les patients recevent des antivitamines K. Rev. Rhum. Mal. Osteoartic. 56, 677-679.
32. Rosen, H. N., Maitland, L. A., Suttie, J. W., Manning, W. J., Glynn, R. J. and Greenspan, S. L. (1993) Vitamin K and maintenance of skeletal integrity in adults. Am. J. Med. 94, 62-68.
33. Piro, L. D., Whyte, M. P., Murphy, W. A. and Birge, S. J. (1982) Normal cortical bone mass in patients after long term coumadin therapy. J. Clin. Endocrinol. Metab. 54, 470-473.
34. Resch, H., Pietschmann, P., Krexner, E. and Willvonseder, R. (1991) Decreased peripheral bone mineral content in patients under anticoagulant therapy with phenprocoumon. Eur. Heart J. 12, 439-441.
35. Monreal, M., Olive, A., Lafoz, E. and Del Rio, L. (1991) Heparins, coumarin, and bone density. Lancet 338, 706.
36. Fiore, C. E., Tamburino, C., Foti, R. and Grimaldi, D. (1990) Reduced bone mineral content in patients taking an oral anticoagulant. South Med. J. 83, 538-542.
37. Sokoll, L. J., Booth, S. L. and Sadowski, J. A. (1995) Changes in undercarboxylated osteocalcin (ucOC) with increased dietary phylloquinone (VK-1), FASEB J. 9, A726 (abstract).
38. Plantalech, L.C., Chapuy, M.C., Guillaumont, M., Chapuy, P., Leclerq, M. and Delmas, P. D. (1990) Impaired carboxylation of serum osteocalcin in elderly women: effect of vitamin K1 treatment. In: Osteoporosis (Christiansen, C. and Overgaard, K., eds.), pp. 345-347, Osteopress Aps, Copenhagen.
39. Douglas, A.S., Robine, S.P., Hutchison, J.D., Porter, R. W., Stewart, A. and Reid, D. M. (1995) Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation. Bone 17, 15-20.
40. Knapen, M. H. J., Hamulyak, K. and Vermeer, C. (1989) The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann. Intern. Med. 111, 1001-1005.
41. 3. J. Bone Mineral Res. 7, (Suppl. 1), S122.
42. Akjba, T., Kurihara, S., Tachibana, K. (1991) Vitamin K (K) increased bone mass (BM) in hemo-dialysis patients (pts) with low-turnover bone disease. (LTOBD) J. Am. Soc. Nephrol. 608, 42P.